Search by Drug Name or NDC
NDC 65197-0204-42 Emetrol Chewables 230 mg/1 Details
Emetrol Chewables 230 mg/1
Emetrol Chewables is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by WellSpring Pharmaceutical Corporation. The primary component is TRISODIUM CITRATE DIHYDRATE.
Product Information
| NDC | 65197-0204 |
|---|---|
| Product ID | 65197-204_052c21bb-93f9-4404-bb23-124a320cb364 |
| Associated GPIs | |
| GCN Sequence Number | 078199 |
| GCN Sequence Number Description | sodium citrate TAB CHEW 230 MG ORAL |
| HIC3 | D4B |
| HIC3 Description | ANTACIDS |
| GCN | 44483 |
| HICL Sequence Number | 000537 |
| HICL Sequence Number Description | SODIUM CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | Emetrol Chewables |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium citrate dihydrate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 230 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRISODIUM CITRATE DIHYDRATE |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65197-0204-42 (65197020442)
| NDC Package Code | 65197-204-42 |
|---|---|
| Billing NDC | 65197020442 |
| Package | 1 BOTTLE in 1 BOX (65197-204-42) / 42 TABLET, CHEWABLE in 1 BOTTLE |
| Marketing Start Date | 2022-03-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |